Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Feb 5;14(1):2988.
doi: 10.1038/s41598-024-52658-4.

Effect of ginger supplementation on the fecal microbiome in subjects with prior colorectal adenoma

Affiliations
Randomized Controlled Trial

Effect of ginger supplementation on the fecal microbiome in subjects with prior colorectal adenoma

Ajay Prakash et al. Sci Rep. .

Abstract

Ginger has been associated with a decreased incidence of colorectal cancer (CRC) through reduction in inflammatory pathways and inhibition of tumor growth. Recent pre-clinical models have implicated changes in the gut microbiome as a possible mediator of the ginger effect on CRC. We hypothesized that, in adults previously diagnosed with a colorectal adenoma, ginger supplementation would alter the fecal microbiome in the direction consistent with its CRC-inhibitory effect. Sixty-eight adults were randomized to take either ginger or placebo daily for 6 weeks, with a 6-week washout and longitudinal stool collection throughout. We performed 16S rRNA sequencing and evaluated changes in overall microbial diversity and the relative abundances of pre-specified CRC-associated taxa using mixed-effects logistic regression. Ginger supplementation showed no significant effect on microbial community structure through alpha or beta diversity. Of 10 pre-specified CRC-associated taxa, there were significant decreases in the relative abundances of the genera Akkermansia (p < 0.001), Bacteroides (p = 0.018), and Ruminococcus (p = 0.013) after 6-week treatment with ginger compared to placebo. Ginger supplementation led to decreased abundances of Akkermansia and Bacteroides, which suggests that ginger may have an inhibitory effect on CRC-associated taxa. Overall, ginger supplementation appears to have a limited effect on gut microbiome in patients with colorectal adenomas.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Study flowchart. Subject population sizes and exclusion criteria for screening, enrollment, and study completion.
Figure 2
Figure 2
Diagram of interventions and sample collections. Overall study design for ginger treatment and subsequent stool and urine sample collections.
Figure 3
Figure 3
Microbiome structure in ginger supplementation. Alpha and beta Diversity analysis of microbiome composition between serial stool samples in subjects being treated with either ginger (orange) or placebo (grey).
Figure 4
Figure 4
Change in taxonomic mean relative abundance with ginger supplementation. Mean relative abundance and 95% confidence intervals of three CRC-associated taxa which demonstrated significant shifts between ginger (orange) and placebo (grey) during the 6-week intervention.

Similar articles

Cited by

References

    1. SEER Cancer Annual Report to the Nation 2021: Overall Cancer Statistics. 2021. https://seer.cancer.gov/report_to_nation/statistics.html.
    1. Howlader, N., et al., SEER Cancer Statistics Review, 1975–2016. National Cancer Institute, Bethesda, MD.
    1. Ahn J, et al. Human gut microbiome and risk for colorectal cancer. J. Natl. Cancer Inst. 2013;105(24):1907–1911. doi: 10.1093/jnci/djt300. - DOI - PMC - PubMed
    1. Kostic AD, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14(2):207–215. doi: 10.1016/j.chom.2013.07.007. - DOI - PMC - PubMed
    1. Peters BA, et al. The gut microbiota in conventional and serrated precursors of colorectal cancer. Microbiome. 2016;4(1):69. doi: 10.1186/s40168-016-0218-6. - DOI - PMC - PubMed

Publication types

Substances